Marshall Wace
VMD icon

Marshall Wace’s Viemed Healthcare VMD Stock Holding History

Marshall Wace’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,081
Closed -$148K – 3795
2026
Q1 		$148K Buy
+16,081
New +$134K ﹤0.01% 2838
2025
Q4 		– Sell
-46,994
Closed -$319K – 3515
2025
Q3 		$319K Buy
46,994
+25,715
+121% +$174K ﹤0.01% 2404
2025
Q2 		$147K Buy
+21,279
New +$144K ﹤0.01% 2501
2024
Q1 		– Sell
-22,574
Closed -$177K – 2830
2023
Q4 		$177K Buy
22,574
+4,974
+28% +$36.1K ﹤0.01% 1996
2023
Q3 		$118K Buy
+17,600
New +$144K ﹤0.01% 2035
2023
Q2 		– Sell
-18,534
Closed -$179K – 2998
2023
Q1 		$179K Buy
+18,534
New +$162K ﹤0.01% 2427
2022
Q4 		– Sell
-140,687
Closed -$844K – 3453
2022
Q3 		$844K Sell
140,687
-5,631
-4% -$36.1K ﹤0.01% 2482
2022
Q2 		$788K Buy
146,318
+40,826
+39% +$220K ﹤0.01% 2577
2022
Q1 		$525K Buy
+105,492
New +$490K ﹤0.01% 2752
2020
Q4 		– Sell
-42,566
Closed -$368K – 2200
2020
Q3 		$368K Buy
+42,566
New +$429K ﹤0.01% 1314

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Marshall Wace's VMD Position: Q2 2026 in Review

Marshall Wace sold out of Viemed Healthcare (VMD) in Q2 2026, closing a stake of 16,081 shares — an estimated $148K sold.

Marshall Wace first reported a position in VMD in Q3 2020 and held it in 10 quarters. The position peaked at $844K in Q3 2022. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Marshall Wace reported no remaining Viemed Healthcare position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 16,081 Viemed Healthcare shares in Q2 2026, an estimated $148K.
  • Marshall Wace first reported a position in Viemed Healthcare in Q3 2020 and held it in 10 quarters.
  • Marshall Wace's Viemed Healthcare position peaked at $844K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.